Ignite Creation Date:
2024-05-05 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00088543
Status:
COMPLETED
Last Update Posted:
2015-03-18
First Post:
2004-07-29
Brief Title:
Thymoglobulin to Prevent Acute Graft vs Host Disease GvHD in Patients With Acute Lymphocytic Leukemia ALL or Acute Myelogenous Leukemia AML Receiving a Stem Cell Transplant
Sponsor:
Genzyme a Sanofi Company
Organization:
Sanofi
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Graft vs Host Disease GvHD |
| Acute Myelogenous Leukemia AML |
| Acute Lymphocytic Leukemia ALL |